Cuvposa Alternatives Compared
Cuvposa | Glycopyrrolate | Glyrx-PF |
|
---|
Cuvposa (glycopyrrolate) | Glycopyrrolate | Glyrx-PF (glycopyrrolate) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Excessive Salivation. Cuvposa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Excessive Salivation, COPD - Maintenance, Anesthesia, Peptic Ulcer. glycopyrrolate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Excessive Salivation, Anesthesia, Peptic Ulcer. Glyrx-PF may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
More about Cuvposa (glycopyrrolate) | More about Glycopyrrolate | More about (glycopyrrolate) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Cuvposa has an average rating of 0.0 out of 10 from a total of 1 ratings on Drugs.com. |
Glycopyrrolate has an average rating of 8.8 out of 10 from a total of 19 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 6% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Cuvposa side effects in more detail. |
See also: glycopyrrolate side effects in more detail. |
See also: Glyrx-PF side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cuvposa prices |
View all glycopyrrolate prices |
View all Glyrx-PF prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other glycopyrrolate brands include: Dartisla ODT, Glycate, Glyrx-PF, Lonhala Magnair | Cuvposa, Dartisla ODT, Glycate, Glyrx-PF, Lonhala Magnair | Other glycopyrrolate brands include: Cuvposa, Dartisla ODT, Glycate, Lonhala Magnair | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 202 drugs are known to interact with Cuvposa:
|
A total of 202 drugs are known to interact with glycopyrrolate:
|
A total of 202 drugs are known to interact with Glyrx-PF:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
July 28, 2010 |
August 11, 1961 |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.